Lienhardt & Partner Core Strategy Fund (CSF) A-CHF

Reference Data

ISIN CH0002789847
Valor Number 278984
Bloomberg Global ID BBG000FZ2LD2
Fund Name Lienhardt & Partner Core Strategy Fund (CSF) A-CHF
Fund Provider Lienhardt & Partner Privatbank Zürich AG Phone: +41 31 399 31 11
E-Mail: info@lienhardt.ch
Web: https://www.lienhardt-bern.ch
Fund Provider Lienhardt & Partner Privatbank Zürich AG
Representative in Switzerland
Distributor(s) Lienhardt & Partner Privatbank Zürich AG
Phone: 41 31 399 31 11
Asset Class Asset Allocation
EFC Category
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The fund invests in shares and first-class bonds.
Peculiarities

Fund Prices

Current Price * 84.53 CHF 26.06.2025
Previous Price * 84.59 CHF 25.06.2025
52 Week High * 87.71 CHF 13.02.2025
52 Week Low * 78.70 CHF 09.04.2025
NAV * 84.53 CHF 26.06.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 105,582,309
Unit/Share Assets *** 18,567,259
Trading Information SIX

Performance

YTD Performance +0.44% 31.12.2024
26.06.2025
1 month -0.18% 26.05.2025
26.06.2025
3 months -0.69% 26.03.2025
26.06.2025
6 months +0.13% 27.12.2024
26.06.2025
1 year -0.97% 26.06.2024
26.06.2025
2 years +8.31% 26.06.2023
26.06.2025
3 years +8.12% 27.06.2022
26.06.2025
5 years +9.70% 26.06.2020
26.06.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 7.2065
ADDI Date 26.06.2025

Top 10 Holdings ***

StructGSQrtxMdfdStgyBlmbrgCmdIdxTRCCHFH 6.16%
Synchrony Swiss Government Bonds 5.25%
Roche Holding AG 4.37%
Amundi BlmbrgEqualweightCmdexAgrETFAcc 3.89%
Nestle SA 3.36%
iShares MSCI Emerging Markets ETF 2.91%
DH Switzerland Finance SA 1.13% 2.86%
Pfandbriefbank schweizerischer Hypothekarinstitute AG 0.63% 2.81%
UBS (CH) PF Swiss Residential Ord 2.77%
Novartis AG Registered Shares 2.76%
Last data update 31.03.2025

Cost / Risk

TER 1.49%
TER date 31.12.2024
Performance Fee ***
PTR 85.00%
Max. Management Fee *** 1.30%
Ongoing Charges *** 1.48%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)